In a patient with an E. coli infection resistant to trimethoprim (dfr A1, A5) and sulfonamides (sul 12), is nitrofurantoin (Macrobid) an appropriate treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Yes, Macrobid (nitrofurantoin) should work effectively for this E. coli infection despite trimethoprim and sulfonamide resistance.

Nitrofurantoin retains excellent activity against E. coli with trimethoprim-sulfamethoxazole (TMP-SMX) resistance and is specifically recommended as first-line therapy for uncomplicated cystitis. 1, 2, 3

Why Nitrofurantoin is Appropriate Here

The resistance genes you've identified (dfr A1, A5 for trimethoprim and sul 12 for sulfonamides) confer resistance to TMP-SMX, but nitrofurantoin works through a completely different mechanism - it's reduced by bacterial nitroreductases (nfsA and nfsB genes) to reactive intermediates that damage bacterial DNA, ribosomes, and other cellular components 4. This means TMP-SMX resistance does not predict nitrofurantoin resistance.

Supporting Evidence

  • Current guidelines list nitrofurantoin as first-line therapy for uncomplicated UTI with 88-93% cure rates, narrow spectrum targeting E. coli specifically, and stable low resistance rates over 50 years 1

  • FDA labeling confirms Macrobid is indicated for acute uncomplicated UTI caused by susceptible E. coli strains 3

  • Resistance data shows only 1.9-2.3% of E. coli isolates (including TMP-SMX-resistant strains) are resistant to nitrofurantoin, compared to 24-29% resistance to TMP-SMX and 12-50% to fluoroquinolones 5, 6, 7, 8, 9

  • Among TMP-SMX-resistant E. coli specifically, 95-98% remain susceptible to nitrofurantoin 5, 7

Dosing and Duration

  • 100 mg twice daily for 5 days for uncomplicated cystitis 1, 2

Critical Caveats

Do NOT use nitrofurantoin if:

  • Patient has pyelonephritis or perinephric abscess - nitrofurantoin lacks adequate tissue distribution outside the urinary tract 3
  • Patient has significantly reduced renal function (CrCl <30 mL/min) - inadequate urinary concentrations
  • This is a complicated UTI requiring broader tissue penetration

If symptoms suggest upper tract involvement (fever, flank pain, systemic symptoms), choose ceftriaxone, a fluoroquinolone, or TMP-SMX based on local resistance patterns instead 2.

Mechanism of Nitrofurantoin Resistance

When nitrofurantoin resistance does occur, it's typically due to mutations in the chromosomal nitroreductase genes (nfsA, nfsB) or ribE gene - not related to TMP-SMX resistance mechanisms 4. The mobile resistance gene oqxAB is extremely rare in UK E. coli (<0.01%) 4.

References

6
Research

Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003

Related Questions

What is the most effective antibiotic for Escherichia coli (E. coli) urinary tract infection (UTI)?
In a patient with a urine culture growing Escherichia coli (10,000‑49,000 CFU/mL) that is susceptible to nitrofurantoin (MIC ≤ 16 µg/mL), does Macrobid (nitrofurantoin) provide appropriate coverage?
What is the next best step for a patient with persistent Escherichia coli (E. coli) urinary tract infection (UTI) and ongoing dysuria after a 5-day course of Macrobid (nitrofurantoin)?
Is Augmentin (amoxicillin-clavulanate) effective for treating Escherichia coli (E. coli) urinary tract infections (UTIs)?
Is Macrobid (Nitrofurantoin) effective against Escherichia coli (E. coli) in a patient with a urine culture positive for E. coli?
What is the most appropriate inhaler for a reactive airway?
After cardioversion for atrial fibrillation, how long should a patient remain on a direct‑acting oral anticoagulant (DOAC) if sinus rhythm is maintained?
What COX‑2 inhibitors (e.g., celecoxib, etoricoxib) can be used in a patient without active gastrointestinal ulcer disease, significant cardiovascular disease, severe renal impairment, or aspirin‑sensitive asthma?
What physical examination and screening tests are recommended for a 73-year-old woman?
Which leukemia, chronic myeloid leukemia (CML) or acute myeloid leukemia (AML), is more common in older individuals?
What is the appropriate infusion rate of normal saline (0.9% sodium chloride) for an adult patient without congestive heart failure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.